Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
deals
4
×
life sciences
national blog main
boston
boston top stories
clinical trials
fda
national top stories
investing
roche
san francisco blog main
akouos
alirocumab
alnylam pharmaceuticals
amgen
astellas pharmaceuticals
avapritinib
biopharma
blueprint medicines
california institute for biomedical research
cstone pharmaceuticals
decibel therapeutics
duchenne
eli lilly
europe blog main
europe top stories
european medicines agency
evolocumab
fisogatinib
flatiron health
frequency therapeutics
genentech
harvard university
hearing loss
hepatocellular carcinoma
inclisiran
jeff albers
jeffrey karp
What
fda
4
×
drug
medicines
approval
billion
deal
roche
therapeutics
acquire
affects
agreed
americans
approved
betting
biopharma
blueprint
brings
cancer
candidate
cash
cholesterol
company
compound
currently
date
developing
duchenne
frequency
gene
hearing
historic
ipo
loss
marketing
medco
medicine
meds
millions
muscle
new
Language
unset
4
×
Current search:
deals
×
unset
×
fda
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds